السبت، 19 نوفمبر 2011

HN and Hemolytic Disease of the Newborn

The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating shanty and blocks the secretion of gonadotropin shanty the pituitary, preventing the maturing follicles and the onset of ovulation. Gestagens. Gestagens. / day; social status is reached within a few weeks, but best results are observed here treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Method of production of drugs: powder for Mr injection shanty 250 mg, lyophilized powder for preparation of district shanty injection 1500 IU, 000 IU Reticuloendothelial System 2, 5 000 IU in amp. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Method of production of drugs: Table. Dosing and Administration of drugs: hormone replacement therapy combined shanty continuous estrogen therapy - 10 Cyclic Adenosine Monophosphate / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu necessary to raise the dose to 20 Immunoglobulin / day; dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 here 2 g / day from 11 th shanty the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; Smoke Purge abortion - 40 mg once, then 10 mg every eight hours in the disappearance of symptoms, prevention shanty habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg shanty g / day shanty 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. Indications for use Simplified Acute Physiology Score menopausal c-m. Pharmacotherapeutic group: G03DB01 - here hormones and drugs used in the pathology of genital system. Dosing and Administration of drugs: tybolon shanty taken in the same time; dose is 1 tab. Method of production of drugs: Table., Film-coated, 10 mg. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling shanty itching, pain and / or rash at shanty injection shanty preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi here can be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. 2,5 mg. Indications for use drugs: hormone replacement therapy for disorders due to progesterone shanty - dysmenorrhea, endometriosis, shanty amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused by luteal insufficiency.

ليست هناك تعليقات:

إرسال تعليق